The Federal Trade Commission has sent warning letters to 24 of the largest healthcare services companies in the U.S., raising concerns that they may not be providing clear pricing information for patients. The letters, signed by FTC Chairman Andrew N. Ferguson, do not name the recipients but highlight potential violations of the FTC Act, which requires accurate, timely, and complete pricing disclosures—especially for non-emergency, scheduled services. The FTC states that price transparency is essential in healthcare, where costs can be unpredictable and financially overwhelming for patients.
Many consumers face significant time and travel burdens to receive care, making upfront cost clarity a necessity. The agency notes that hospitals and providers often charge vastly different prices for the same services, leaving consumers vulnerable to unexpected expenses. While the Centers for Medicare & Medicaid Services (CMS) requires hospitals to publish machine-readable pricing files and offer good-faith estimates for uninsured or self-pay patients, the FTC argues that compliance with CMS rules does not automatically satisfy the stricter FTC Act requirements. The agency treats pricing as a “material term,” meaning consumers must receive clear, conspicuous, and complete disclosures to avoid deception.
The warning letters highlight that incomplete or misleading pricing information, such as omitting fees like physician or facility charges, could mislead patients into believing they understand the total cost. The FTC warns that even partial disclosures may violate its rules if they fail to reflect the full financial burden of care. The letters do not accuse the companies of wrongdoing but urge them to review their practices and correct any deficiencies. The FTC’s focus on healthcare pricing aligns with broader efforts to hold businesses accountable for deceptive practices.
The agency has previously targeted rental housing, hotels, and grocery delivery for similar issues. Without clear pricing, consumers cannot make informed decisions, particularly in healthcare, where costs can be life-altering. This enforcement action reflects the FTC’s broader mission: ensuring that consumers have the information they need to avoid financial surprises in critical services. While the warning letters signal potential enforcement actions, they do not confirm violations. The agency’s approach emphasizes that businesses must provide complete and accurate pricing details to prevent deception and protect patients from unexpected expenses.
